Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.75 - $1.77 $128,535 - $303,342
-171,380 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$1.56 - $2.93 $32,872 - $61,740
21,072 Added 14.02%
171,380 $278,000
Q3 2021

Nov 12, 2021

BUY
$2.91 - $4.83 $200,240 - $332,357
68,811 Added 84.43%
150,308 $451,000
Q4 2019

Feb 12, 2020

SELL
$8.49 - $12.81 $2.56 Million - $3.86 Million
-301,125 Reduced 78.7%
81,497 $719,000
Q3 2019

Nov 13, 2019

SELL
$5.58 - $14.47 $187,058 - $485,077
-33,523 Reduced 8.06%
382,622 $4.29 Million
Q2 2019

Aug 07, 2019

BUY
$5.22 - $9.08 $1.18 Million - $2.05 Million
225,250 Added 118.0%
416,145 $2.52 Million
Q1 2019

May 08, 2019

BUY
$5.35 - $9.82 $439,390 - $806,506
82,129 Added 75.51%
190,895 $1.5 Million
Q4 2018

Feb 12, 2019

BUY
$3.43 - $6.19 $86,411 - $155,944
25,193 Added 30.14%
108,766 $539,000
Q3 2018

Nov 13, 2018

SELL
$4.75 - $14.5 $643,762 - $1.97 Million
-135,529 Reduced 61.86%
83,573 $397,000
Q2 2018

Aug 02, 2018

BUY
$13.3 - $17.45 $2.27 Million - $2.97 Million
170,425 Added 350.11%
219,102 $2.98 Million
Q1 2018

May 14, 2018

BUY
$14.7 - $24.95 $715,551 - $1.21 Million
48,677 New
48,677 $781,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.